Usharani P, Nutalapati C, Pokuri VK, Kumar CU, Taduri G
As we continue to innovate in the field of diabetes drugs, the focus on patient-centric solutions will remain paramount
In mid-2025, over 50 insurers pledged to answer 80% of electronic PA requests in real time by 2027 ( [13] ) ( [14] ), and these AHIP commitments took effect on January 1, 2026 ( [15] )
10.7860/JCDR/2016/23668.8980 J Clin Diagn Res
So, while the explanation touches on real aspects of neuropathy and B12 deficiency, it might oversimplify or misrepresent some of the complex interactions in the nervous system
The dosing framework is similar but with additional glycemic monitoring requirements